摘要:
An oral pharmaceutical composition comprising 3-hydroxy 2,4,6 trimethylpyridine, pharmaceutically acceptable salts, esters, derivatives and polymorphs thereof for the treatment of ischemia, intraocular hemorrhage and macular degeneration is disclosed.
摘要:
The invention relates to the field of medicine, namely to new biologically active compounds, particularly to 2,4,6-trimethyl-3-hydroxypiridine derivatives and salts thereof (compound 1), having antioxidant, geroprotective and anti-ischemic action. The salts of compound (1) are prepared by reacting equimolecular quantities of 2,4,6-trimethyl-3-hydroxypiridine and dicarboxylic in solution of the lower spirit at the temperature of 60-100°C with following processing of the reactionary bulk by organic solvent and incubating within 2-5 h at 10-15°C.
摘要:
A pharmaceutically acceptable injection formulation comprising 3-hydroxy 2, 4,6 trimethylpyridine, pharmaceutically acceptable salts, esters, derivatives and polymorphs thereof for the treatment of ischemia, intraocular hemorrhage and macular degeneration is disclosed.
摘要:
An ophthalmic composition comprising 3-hydroxy 2,4,6 trimethylpyridine, pharmaceutically acceptable salts, esters, derivatives and polymorphs thereof for the treatment of intraocular hemorrhage and macular degeneration is disclosed.
摘要:
The invention relates to the field of medicine, namely to new biologically active compounds, particularly to 2,4,6-trimethyl-3-hydroxypyridine derivatives and salts thereof (compound 1) having antioxidant, geroprotective and anti-ischemic action. The salts of compound (1) are prepared by reacting equimolecular quantities of 2,4,6-trimethyl-3-hydroxypyridine and dicarboxylic in solution of a lower alcohol at a temperature of 60-100°C with following treatment of the reaction mass with an organic solvent and maintaining for 2-5 h at 10-15 °C.